A Randomized Comparison Of LDR or HDR Brachytherapy Boost Combined With Pelvic External Beam Radiation For Unfavorable Intermediate or High-risk Prostate Cancer. Efficacy Results At 6 Years Follow Up

episode

American Brachytherapy Society (ABS) Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

OTHER PEOPLE VS ME || Funny Relatable Situations and Fails by 123 GO! 11 min · 25 Sep 2026 · 123 GO!

NHL Pacific Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 8PM EDT 4 min · 25 Sep 2026 · NPR News Now

Fletch, Vaughan & Hayley's Lil Bitta Pod - 25th September 2026 7 min · 25 Sep 2026 · ZM's Fletch, Vaughan & Hayley

Send Me To Sleep | Orchards 48 min · 25 Sep 2026 · Send Me To Sleep

Fletch, Vaughan & Hayley's Big Pod - 25th September 2026 1h 27m · 25 Sep 2026 · ZM's Fletch, Vaughan & Hayley

Report any issue

Source

Recorded11 Sep 2024

Publisheranchor.fm ↗

Handlerec:12342884

Show notes

JC Cheng is a Brachytherapy fellow under Dr. Juanita Crook at Univeristy of British Columbia. We discussed the plenary session at the World Congress that explored LDR vs HDR boost for combination therapy in unfavorable and high risk prostate cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related